Safety Study to Evaluate LY3114062 in Participants With Inflammatory Arthritis

Clinical trial NCT02144272 · COMPLETED

Trial details

NCT number: NCT02144272
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Inflammatory Arthritis

Start date: 2014-06-01
Primary completion: 2015-05-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.